Liver transplantation: Current status and challenges

Decreased chronic cellular and antibody-mediated injury in the kidney following simultaneous liver-kidney transplantation

(2016) Timucin Taner et al.   KIDNEY INTERNATIONAL

First Comparison of Hypothermic Oxygenated PErfusion Versus Static Cold Storage of Human Donation After Cardiac Death Liver Transplants

(2015) Philipp Dutkowski et al.   ANNALS OF SURGERY

De novodonor-specific anti-HLA antibodies mediated rejection in liver-transplant patients

(2015) Arnaud Del Bello et al.   TRANSPLANT INTERNATIONAL

Hypothermic Machine Preservation Facilitates Successful Transplantation of “Orphan” Extended Criteria Donor Livers

(2014) J. V. Guarrera et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Antibody-mediated rejection in liver transplantation: Current controversies and future directions

(2014) Timucin Taner et al.   LIVER TRANSPLANTATION

Early allograft dysfunction in liver transplantation using donation after cardiac death donors results in inferior survival

(2014) David D. Lee et al.   LIVER TRANSPLANTATION

Antibody-mediated rejection despite inhibition of terminal complement

(2014) Andrew Bentall et al.   TRANSPLANT INTERNATIONAL

Ex vivoNormothermic Machine Perfusion and Viability Testing of Discarded Human Donor Livers

(2013) S. op den Dries et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients

(2013) Carlos Benítez et al.   HEPATOLOGY

HOPE for human liver grafts obtained from donors after cardiac death

(2013) Philipp Dutkowski et al.   JOURNAL OF HEPATOLOGY

Calcineurin Inhibitor-Free Mycophenolate Mofetil/Sirolimus Maintenance in Liver Transplantation: The Randomized Spare-the-Nephron Trial

(2013) Lewis Teperman et al.   LIVER TRANSPLANTATION

Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival

(2013) Alexandre Loupy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prevalence, Course and Impact of HLA Donor-Specific Antibodies in Liver Transplantation in the First Year

(2012) T. Taner et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Intragraft Gene Expression in Positive Crossmatch Kidney Allografts: Ongoing Inflammation Mediates Chronic Antibody-Mediated Injury

(2012) P. G. Dean et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Hypothermic Machine Preservation Reduces Molecular Markers of Ischemia/Reperfusion Injury in Human Liver Transplantation

(2012) S. D. Henry et al.   AMERICAN JOURNAL OF TRANSPLANTATION

A New Diagnostic Algorithm for Antibody-Mediated Microcirculation Inflammation in Kidney Transplants

(2012) B. Sis et al.   AMERICAN JOURNAL OF TRANSPLANTATION

A Randomized, Controlled Study to Assess the Conversion From Calcineurin-Inhibitors to Everolimus After Liver Transplantation-PROTECT

(2012) L. Fischer et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Complete Immunosuppression Withdrawal and Subsequent Allograft Function Among Pediatric Recipients of Parental Living Donor Liver Transplants

(2012) Sandy Feng et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Donor-specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with Chronic rejection and graft loss after liver transplantation

(2012) Hugo Kaneku et al.   LIVER TRANSPLANTATION

Machine Perfusion or Cold Storage in Deceased-Donor Kidney Transplantation

(2012) Cyril Moers et al.   NEW ENGLAND JOURNAL OF MEDICINE

High Mean Fluorescence Intensity Donor-Specific Anti-HLA Antibodies Associated With Chronic Rejection Postliver Transplant

(2011) J. G. O’Leary et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors

(2011) C. Burcin Taner et al.   LIVER TRANSPLANTATION

Significance of complement split product C4d in ABO-compatible liver allograft: Diagnosing utility in acute antibody mediated rejection

(2011) Sharif Ali et al.   TRANSPLANT IMMUNOLOGY

Daclizumab induction therapy in liver transplant recipients with renal insufficiency

(2010) S. K. Asrani et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Early Withdrawal of Calcineurin Inhibitors and Everolimus Monotherapy in de novo Liver Transplant Recipients Preserves Renal Function

(2010) M. Masetti et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Evolution of Causes and Risk Factors for Mortality Post-Liver Transplant: Results of the NIDDK Long-Term Follow-Up Study

(2010) K. D. S. Watt et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Use of sirolimus in liver transplant recipients with renal insufficiency: A systematic review and meta-analysis

(2010) Sumeet K. Asrani et al.   HEPATOLOGY

Evidence for Antibody-Mediated Injury as a Major Determinant of Late Kidney Allograft Failure

(2010) Robert S. Gaston et al.   TRANSPLANTATION

C1q-Fixing Human Leukocyte Antigen Antibodies Are Specific for Predicting Transplant Glomerulopathy and Late Graft Failure After Kidney Transplantation

(2010) Julie M. Yabu et al.   TRANSPLANTATION

Normothermic Perfusion

(2009) Jens Brockmann et al.   ANNALS OF SURGERY

Relationship between renal resistance index and renal function in liver transplant recipients after cessation of calcineurin inhibitor

(2009) Ute Eisenberger et al.   CLINICAL TRANSPLANTATION

Alloantibody Levels and Acute Humoral Rejection Early After Positive Crossmatch Kidney Transplantation

(2008) J. M. Burns et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Delayed Introduction of Reduced-Dose Tacrolimus, and Renal Function in Liver Transplantation: The ‘ReSpECT' Study

(2008) J. M. Neuberger et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens

(2008) Derek DuBay et al.   LIVER TRANSPLANTATION

Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection

(2008) Matthew J. Everly et al.   TRANSPLANTATION